[1]王福亭.致康胶囊对溃疡性结肠炎患者血清TNF-α、IL-6及CRP的影响[J].西部中医药,2016,29(02):100-102.
 WANG Futing.Influence of ZhiKang Capsules on Serum TNF-α, IL-6 and CRP of the Patients with Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2016,29(02):100-102.
点击复制

致康胶囊对溃疡性结肠炎患者血清TNF-α、IL-6及CRP的影响()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
29
期数:
2016年02期
页码:
100-102
栏目:
出版日期:
2016-02-15

文章信息/Info

Title:
Influence of ZhiKang Capsules on Serum TNF-α, IL-6 and CRP of the Patients with Ulcerative Colitis
文章编号:
1004-6852(2016)02-0100-03
作者:
王福亭
甘肃省中医院白银分院脾胃病科,甘肃 白银 730900
Author(s):
WANG Futing
Gastroenterology Department of Baiyin Branch of Gansu Provincial Hospital of Traditional Chinese Medicine, Baiyin 730900, China
关键词:
溃疡性结肠炎致康胶囊肿瘤坏死因子-α白介素-6C反应蛋白血凝状态生活质量
Keywords:
ulcerative colitis ZhiKang capsules TNF-α IL-6 CRP blood coagulation state quality of life
分类号:
R574.62
文献标志码:
B
摘要:
目的:观察致康胶囊治疗溃疡性结肠炎的疗效及对患者血清肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)及C反应蛋白(CRP)的影响。方法:将58例患者随机分为观察组和对照组,每组29例。对照组给予常规治疗。观察组在此基础上,给予致康胶囊治疗。结果:总有效率观察组为96.55%,对照组为72.41%,2组比较差异有统计学意义(P<0.05)。治疗后血清TNF-α、IL-6、CRP观察组分别为(23.5±2.7)ng/L、(31.6±1.3)ng/L、(3.2±0.9)mg/L,对照组分别为(47.2±5.8)ng/L、(47.3±4.5)ng/L、(5.1±1.2)mg/L,2组比较差异有统计学意义(P<0.05)。治疗后,纤维蛋白原(FIB)、血小板计数(PLT)、血小板平均体积(MPV)观察组分别为(3.0±0.8)g/L、(209.7±45.3)×109/L、(9.0±1.4)fL,对照组分别为(4.1±0.3)g/L、(236.1±39.5)×109/L、(12.1±1.2)fL,2组比较差异均有统计学意义(P<0.05)。治疗后,血小板最大聚集率(PAGMax)指标观察组高于对照组(P<0.05)。治疗后,白蛋白水平观察组为(31.4±2.1)g/L,对照组为(28.1±2.0)g/L,2组比较差异有统计学意义(P<0.05)。治疗后,生活质量评分观察组为(82.3±9.2)分,对照组为(76.4±7.8)分, 2组比较差异有统计学意义(P<0.05)。结论:致康胶囊治疗溃疡性结肠炎疗效显著,能够降低患者血清TNF-α、IL-6及CRP水平,减轻炎症反应程度,改善患者血凝状态,并有效提高患者生活质量。
Abstract:
Objective: To observe clinical effects of ZhiKang capsules in treating ulcerative colitis (UC) and its influence of ZhiKang capsules on TNF-α, IL-6 and CRP of the patients. Methods: All 58 patients were randomized into the observation group and the control group, 29 cases each group. The control group accepted routine treatment. The observation group took ZhiKang capsules on the basis of routine treatment. Results: Total effective rates of the observation group and the control group were 96.55% and 72.41%, the difference had statistical meaning between both groups (P<0.05). After treating, the concentrations of TNF-α, IL-6 and CRP in the observation group were (23.5±2.7) ng/L, (31.6±1.3) ng/L and (3.2±0.9)mg/L, lower than (47.2±5.8) ng/L, (47.3±4.5)ng/L and (5.1±1.2) mg/L, the difference had statistical meaning between both groups (P<0.05). After treating, the concentrations of FIB, PLT and MPV in the observation group were (3.0±0.8)g/L, (209.7±45.3)×109 g/L and (9.0±1.4)fL, lower than (4.1±0.3) g/L, (236.1±39.5)×109 g/L and (12.1±1.2)fL of the control group, the difference showed statistical meaning (P<0.05). After treating, the observation group was higher than the control group in PAGMax indexes (P<0.05). After treating, the levels of albumin in the observation group were (31.4±2.1) g/L, higher than (28.1±2.0) g/L of the control group, the difference presented statistical meaning between both groups (P<0.05). After treating, quality of life(QOL) scales in the observation group were(82.3±9.2), higher than (76.4±7.8) of the control group, and the difference showed statistical meaning between both groups (P<0.05). Conclusion: ZhiKang capsules are effective in treating UC patients, they could decrease the levels of TNF-α, IL-6 and CRP of the patients, relieve the degrees of inflammation, improve blood coagulation state of the patients and effectively improve QOL of the patients.

相似文献/References:

[1]李明彦,刘召.三黄汤口服并灌肠治疗溃疡性结肠炎临床观察[J].西部中医药,2014,27(11):127.
[2]崔童.肠安康胶囊联合美沙拉嗪治疗溃疡性结肠炎疗效观察[J].西部中医药,2015,28(01):78.
[3]孙军刚,刘琦,吴巧凤△.针刺对溃疡性结肠炎Th17/Treg免疫平衡的调节作用[J].西部中医药,2015,28(01):129.
[4]杨斌,王碧霞.美沙拉嗪栓联合穴位贴治疗溃疡性结肠炎中期效果探讨[J].西部中医药,2015,28(05):112.
[5]张军,叶玉伟.中医药治疗溃疡性结肠炎研究进展概况[J].西部中医药,2013,26(12):150.
 ZHANG Jun,YE Yuwei.A Survey of TCM in Treating Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2013,26(02):150.
[6]陈晨.中药保留灌肠治疗急性期溃疡性结肠炎的研究[J].西部中医药,2014,27(05):135.
 CHEN Chen.Research on Retention Enema with Herbs in Treating Ulcerative Colitis at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2014,27(02):135.
[7]李有成,严文有,陈俊英,等.加味阳和四神汤/浸膏剂治疗慢性溃疡性结肠炎疗效观察[J].西部中医药,2014,27(05):104.
 LI Youcheng,YAN Wenyou,CHEN Junying,et al.Observation on Modified YangHe SiShen Decoction or Extract in Treating Chronic Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2014,27(02):104.
[8]张亮,王玮,邱连利△.温通针法治疗脾肾阳虚型溃疡性结肠炎35例[J].西部中医药,2017,30(12):100.
 ZHANG Liang,WANG Wei,QIU Lianli.Warming Needling Method in Treating 35 Cases of Ulcerative Colitis of Spleen-kidney Yang-deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2017,30(02):100.
[9]周春芳.强肝软坚汤加味治疗溃疡性结肠炎机制研究[J].西部中医药,2018,31(03):97.
 ZHOU Chunfang.Study on the Mechanism of Modified Liver-strengthening Mass-softening Decoction in Treating Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(02):97.
[10]张慧田,周知然,雷云霞△.益气除湿法联合美沙拉嗪治疗溃疡性结肠炎临床观察[J].西部中医药,2018,31(05):87.
 ZHANG Huitian,ZHOU Zhiran,LEI Yunxia.Clinical Observation on Qi-invigorating Damp-eliminating Method Combined with Mesalazine in Treating Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(02):87.

备注/Memo

备注/Memo:
作者简介:王福亭(1969—),男,主治医师。研究方向:消化系统疾病的中西医结合诊治。
更新日期/Last Update: 2016-02-15